Unicycive Therapeutics, Inc. (UNCY) Operating income 2020–2025
Unicycive Therapeutics, Inc. (UNCY) annual operating income history from SEC filings — each fiscal year as reported.
-$29.5MFY2025 · since FY2020: -$2.0M → -$29.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.5M | +8.1% |
| FY2024 | -$32.1M | -54.6% |
| FY2023 | -$20.8M | -15.1% |
| FY2022 | -$18.1M | -101.1% |
| FY2021 | -$9.0M | -344.4% |
| FY2020 | -$2.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice